Ophthalmology Medical Service Market Report 2026

The ophthalmology medical service market size has grown strongly in recent years. It will grow from $49.11 billion in 2025 to $52.17 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to limited availability of specialized ophthalmic care, reliance on traditional surgical methods, low awareness of eye disease prevention, increasing prevalence of cataract and glaucoma, inadequate diagnostic infrastructure.

The ophthalmology medical service market size is expected to see strong growth in the next few years. It will grow to $65.9 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to advancements in imaging technologies like oct and fundus photography, growth in cataract and refractive surgeries, increasing adoption of tele-ophthalmology services, rising government initiatives for eye care, growth of personalized ophthalmology treatments through genomics and biotech. Major trends in the forecast period include rising adoption of advanced diagnostic tools in ophthalmology, growing demand for refractive and vision correction procedures, increasing use of minimally invasive surgical techniques, expansion of tele-ophthalmology and remote patient monitoring, rising focus on pediatric and geriatric ophthalmology services.

The rising prevalence of pediatric eye conditions is expected to drive growth in the ophthalmology medical service market in the coming years. Pediatric eye conditions encompass a range of vision problems and eye disorders affecting children from birth through adolescence. This increase is largely due to higher screen time on digital devices, which can cause eye strain, dryness, and a greater likelihood of developing myopia (nearsightedness) at an early age. Ophthalmology medical services play a vital role in managing pediatric eye conditions by offering early diagnosis, specialized treatments, and preventive care to support healthy visual development in children. For example, in September 2024, according to BMJ Group, a UK-based healthcare knowledge provider, global myopia cases are projected to reach 600 million by 2030 and surpass 740 million by 2050, representing about 40% of the world’s population. This growing prevalence of pediatric eye conditions is driving demand for ophthalmology medical services.

Leading companies in the ophthalmology medical service market are focusing on innovative technologies, such as SmartTracker 2 fixation tracking, to improve diagnostic accuracy, streamline workflows, and enhance patient comfort. SmartTracker 2 is an advanced system used in ophthalmic diagnostic devices to monitor and track a patient’s eye fixation during tests. For instance, in January 2024, OCULUS Inc., a US-based manufacturer of ophthalmic diagnostic devices, launched the Easyfield VR, a virtual reality headset designed for efficient and patient-friendly vision screenings. The device supports visual field exams, color vision, contrast sensitivity, and stereo vision tests, while streamlining clinical workflows, enhancing patient comfort, and integrating seamlessly with existing OCULUS diagnostic equipment to improve testing efficiency and overall patient care.

In January 2025, Cencora Inc., a US-based healthcare solutions provider, acquired Retina Consultants of America for approximately $4.6 billion. This acquisition enables Cencora to strengthen its specialty healthcare offerings, expand its management services organization (MSO) solutions, and deliver enhanced value to stakeholders, including physicians and patients. Retina Consultants of America is a US-based company specializing in retinal treatments and providing ophthalmology medical services.

Major companies operating in the ophthalmology medical service market are Johnson & Johnson Vision Care Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Medtronic plc, Regeneron Pharmaceuticals Inc., Alcon Inc., Hoya Corporation, Bausch & Lomb Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Lumenis Be Ltd., Staar Surgical Company, Heidelberg Engineering GmbH, Rayner Surgical Group Limited, Iridex Corporation, Ellex Medical Lasers, Kowa Co. Ltd., TearLab Corporation.

North America was the largest region in the ophthalmology medical service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmology medical service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmology medical service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the ophthalmology medical service market by increasing the cost of imported diagnostic devices, surgical instruments, and medications. Hospitals, medical institutes, and healthcare service providers in north america, europe, and asia-pacific are most impacted due to dependence on imported ophthalmic technologies. However, tariffs also encourage local manufacturing, promote investment in domestic diagnostic device production, and stimulate innovation in advanced surgical and vision correction solutions.

The ophthalmology medical service market research report is one of a series of new reports that provides ophthalmology medical service market statistics, including ophthalmology medical service industry global market size, regional shares, competitors with a ophthalmology medical service market share, detailed ophthalmology medical service market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmology medical service industry. This ophthalmology medical service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ophthalmology medical services involve the diagnosis, treatment, and prevention of eye diseases and disorders. These services include both surgical and non-surgical interventions aimed at preserving and restoring vision through specialized procedures, medications, and ongoing care.

The main services in ophthalmology medical care include vision correction services, diagnostic services, and treatment services. Vision correction services involve medical treatments and devices - such as eyeglasses, contact lenses, laser surgery, and implants - designed to improve or restore vision by addressing refractive errors and other eye conditions. The product types include devices and medications, serving different age groups, including pediatric, adult, and geriatric populations. Ophthalmology medical services address various conditions such as glaucoma, cataract, age-related macular degeneration, and refractive disorders, and are utilized by end users including hospitals, medical institutes and research organizations, healthcare service providers, and government and academic institutions.

The ophthalmology medical service market includes revenues earned by entities by providing services such as pediatric ophthalmology, oculoplastic surgery, and glaucoma management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.